Streetbeat News

Products Services

NNDM

Nano Dimension has filed for a patent for 'Large Language Models for Efficient Anomaly Detection in Log Files of Industrial Machines'. The patent was developed by DeepCube, Nano Dimension's in-house deep learning-based AI group. This innovation is central to Nano Dimension's efforts in AI-driven solutions for advanced manufacturing systems, focusing on default detection and preventive maintenance.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:43 pm

ENS

EnerSys, a global leader in stored energy solutions for industrial applications, has announced the launch of its NexSys AIR Wireless Charger, a new product designed to provide wireless charging solutions for various applications. This innovation represents a step forward in the company's product offerings, potentially opening up new markets and applications for wireless energy solutions.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:42 pm

PHIO

Phio Pharmaceuticals will present new preclinical data for its INTASYL platform at the 10th Immunotherapy of Cancer Conference in Germany. This event could potentially highlight the effectiveness and progress of Phio's INTASYL technology in the field of cancer immunotherapy.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:40 pm

NVO

Novo Nordisk A/S (NYSE:NVO) reported Q4 2023 sales of $9.5 billion, exceeding consensus estimates and showing a 37% increase in Danish kroner and 43% at CER year-over-year. The growth was driven by Diabetes and Obesity care, with GLP-1 diabetes sales up 62% and Obesity care sales up 114% at CER. Wegovy sales rose 293% Y/Y, while insulin and rare disease sales declined. The company has begun increasing US supply of lower dose Wegovy and plans a gradual international rollout. Novo Nordisk forecasts 18%-26% sales growth and 21%-29% operating profit growth for 2024. NVO shares rose 1.48% in premarket trading.

Portfolio Pulse from Vandana Singh

January 31, 2024 | 1:39 pm

BSX

Boston Scientific (BSX) shares rose following the announcement of Q4 financial results that exceeded expectations. The company also provided positive guidance and revealed it has received FDA approval for its FARAPULSE Pulsed Field Ablation System, which is expected to bolster its product portfolio and potentially increase future revenues.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:39 pm

ME

23andMe Holding Co. (NASDAQ:ME) has received FDA approval for its investigational new drug, 23ME-01473, aimed at treating cancer. The drug, an NK cell activator targeting ULBP6 protein on cancer cells, will enter Phase 1 clinical trials in the first half of 2024. This news comes after the company faced security breaches in October and December 2023, affecting customer genetic and ancestry data.

Portfolio Pulse from Benzinga Neuro

January 31, 2024 | 1:38 pm

BLIN

Bridgeline Digital, Inc. has expanded its partnership with an unnamed electrical distributor, with the total contract now valued at over $875,000. This expansion is expected to enhance the distributor's online presence and sales through Bridgeline's eCommerce solutions.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:36 pm

DCTH

Delcath Systems has been granted a permanent J-Code for HEPZATO, which is likely to facilitate billing and reimbursement processes for its liver-directed cancer therapy. This development could enhance the adoption and usage of HEPZATO by healthcare providers, potentially leading to increased revenue for Delcath Systems.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:36 pm

AMSC

ENSC

PARA

Ensysce Biosciences (ENSC) reported the completion of a successful end-of-Phase 2 meeting with the FDA for its analgesic PF614, with Phase 3 enrollment starting mid-2024. Allen Media Group offered $14.3 billion to acquire Paramount Global (PARA), as reported by the Wall Street Journal. AMSC shares dropped after announcing a proposed public offering of common stock.

Portfolio Pulse from ryanfaloona@benzinga.com

January 31, 2024 | 1:36 pm

UPXI

Upexi's subsidiary, Tytan Toys, has expanded its distribution by entering into a partnership with PriceSmart. This move is expected to increase Tytan Toys' market presence and potentially boost sales through PriceSmart's membership shopping warehouse clubs in Central America and the Caribbean.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:34 pm